血管内動脈瘤修復市場：適応症別（腹部大動脈瘤（Aaa）、胸部大動脈瘤（Taa））、部位別（腎内、腎外）、解剖別（伝統的、複雑）、製品別（経皮エバー、フェネトレーテッドエバー、大動脈ステント＆Taaグラフト、その他）。世界の機会分析および産業予測、2020-2030年

Endovascular Aneurysm Repair Market By Indication (Abdominal Aortic Aneurysm (Aaa), Thoratic Aortic Aneurysm (Taa)), By Site (Infrarenal, Pararenal), By Anatomy (Traditional, Complex), By Product (Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

世界の血管内動脈瘤修復市場は、2020年に26億4660万ドル、2030年には43億5620万ドルに達し、2020年から2030年まで年平均成長率4.8％で成長すると予測されます。血管内動脈瘤修復術（EVAR）は、開腹手術と比較し... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,769 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	170	英語

サマリー

世界の血管内動脈瘤修復市場は、2020年に26億4660万ドル、2030年には43億5620万ドルに達し、2020年から2030年まで年平均成長率4.8％で成長すると予測されます。
血管内動脈瘤修復術（EVAR）は、開腹手術と比較した場合の優位性により、大動脈瘤の治療オプションとして好まれています。その利点とは、入院期間の短縮、回復時間の短縮、患者の予後改善、開腹手術が不要であることなどです。そのため、このEVARは腹部大動脈瘤に対する標準的な治療法として知られています。この手術では、大動脈の動脈瘤部にステントを留置し、患者さんの血管内に血流の代替路を永久的に確保することで、動脈瘤嚢の血流圧や破裂を防ぐことができるのです。
EVARは、従来の開腹手術に比べて手術のリスクや回復に要する時間が大幅に短縮されましたが、EVARにはまだ改良の余地があります。これは、EVAR術後にエンドリークが発生する事例があることに起因しています。しかし、このような課題に対応するため、市場参加者は次世代の先端技術を開発しています。例えば、Endologix Inc.は経皮内挿術デリバリーシステムのFDA承認を取得し、あらゆる種類のエンドリークを防ぐのに有効な最初で唯一の血管内シーリング製品である画期的な新世代Nellix技術を持っています。

肺塞栓症、心疾患、動脈硬化などの血管系疾患の増加は、治療のためのグラフト需要を増加させ、EVAR市場の成長を牽引しています。.さらに、政府は動脈瘤治療の手順やデバイスの可用性に関連する意識を高めるためのイニシアチブを取っている。EVARの治療手順や人々の意識の欠如に関連するコストの上昇は、市場の成長を妨げると予想される要因のいくつかである。

テルモメディカル株式会社、Koninklijike Philips N.V.、Medtronic PLC.などの大手企業は、市場での競争を維持するために、製品ポートフォリオを向上させる製品発売戦略を採用しています。例えば、2020年12月、テルモは米国で大動脈バルーンの最初の商用ケースを発売しました。このデバイスは、血管内大動脈修復でTREOおよびRELAYステントグラフトを使用して、大動脈の拡張で医師を支援します。このような事例は、市場成長のために主要なプレーヤーに有利な機会を提供することが期待されます。
COVID-19の大流行により、世界のEVAR市場の多くの企業は、新しい政府規制を遵守し、病気の広がりを制限するために短期的に事業活動を停止することを余儀なくされました。この事業停止は、EVARの世界市場の収益に直接影響を及ぼしました。また、操業停止期間中は原材料や人材が不足したため、工業製品の製造が停止しました。さらに、この分野で事業を展開する企業では、新規の荷受が行われませんでした。このように、産業活動の停止や数ヶ月に及ぶ操業停止は、EVARの世界市場に影響を与えましたが、予測期間中に徐々に回復しています。

EVAR市場は、適応症、製品、部位、解剖学的構造、地域によって区分されます。適応症によって、AAAと胸部大動脈瘤（TAA）に分けられます。部位により、腎臓下と腎臓傍とに二分されます。解剖学的には、伝統的なものと複雑なものに分類されます。製品別では、経皮的EVAR、fenestrated EVAR、大動脈ステント＆TAAグラフト、その他に分類されます。.適応症別では、2020年にAAA分野が77.9%と圧倒的なシェアを占め、TAAは全世界でAAA疾患の発生率が高いことから、予測期間中もこの傾向を維持すると予想される。
地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。北米は予測期間中、最も高い市場シェアを占めると予想されます。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Abdominal Aortic Aneurysm (Aaa)
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Thoratic Aortic Aneurysm (Taa)
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE
5.1 Overview
5.1.1 Market size and forecast
5.2 Infrarenal
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Pararenal
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY
6.1 Overview
6.1.1 Market size and forecast
6.2 Traditional
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Complex
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT
7.1 Overview
7.1.1 Market size and forecast
7.2 Percutaneous Evar
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Fenestrated Evar
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Aortic Stents & Taa Graft
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Indication
8.2.3 North America Market size and forecast, by Site
8.2.4 North America Market size and forecast, by Anatomy
8.2.5 North America Market size and forecast, by Product
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Indication
8.2.6.1.2 Market size and forecast, by Site
8.2.6.1.3 Market size and forecast, by Anatomy
8.2.6.1.4 Market size and forecast, by Product
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Indication
8.2.6.2.2 Market size and forecast, by Site
8.2.6.2.3 Market size and forecast, by Anatomy
8.2.6.2.4 Market size and forecast, by Product
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Indication
8.2.6.3.2 Market size and forecast, by Site
8.2.6.3.3 Market size and forecast, by Anatomy
8.2.6.3.4 Market size and forecast, by Product
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Indication
8.3.3 Europe Market size and forecast, by Site
8.3.4 Europe Market size and forecast, by Anatomy
8.3.5 Europe Market size and forecast, by Product
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Indication
8.3.6.1.2 Market size and forecast, by Site
8.3.6.1.3 Market size and forecast, by Anatomy
8.3.6.1.4 Market size and forecast, by Product
8.3.6.2 Italy
8.3.6.2.1 Market size and forecast, by Indication
8.3.6.2.2 Market size and forecast, by Site
8.3.6.2.3 Market size and forecast, by Anatomy
8.3.6.2.4 Market size and forecast, by Product
8.3.6.3 France
8.3.6.3.1 Market size and forecast, by Indication
8.3.6.3.2 Market size and forecast, by Site
8.3.6.3.3 Market size and forecast, by Anatomy
8.3.6.3.4 Market size and forecast, by Product
8.3.6.4 Spain
8.3.6.4.1 Market size and forecast, by Indication
8.3.6.4.2 Market size and forecast, by Site
8.3.6.4.3 Market size and forecast, by Anatomy
8.3.6.4.4 Market size and forecast, by Product
8.3.6.5 Rest of Europe
8.3.6.5.1 Market size and forecast, by Indication
8.3.6.5.2 Market size and forecast, by Site
8.3.6.5.3 Market size and forecast, by Anatomy
8.3.6.5.4 Market size and forecast, by Product
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Indication
8.4.3 Asia-Pacific Market size and forecast, by Site
8.4.4 Asia-Pacific Market size and forecast, by Anatomy
8.4.5 Asia-Pacific Market size and forecast, by Product
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Indication
8.4.6.1.2 Market size and forecast, by Site
8.4.6.1.3 Market size and forecast, by Anatomy
8.4.6.1.4 Market size and forecast, by Product
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Indication
8.4.6.2.2 Market size and forecast, by Site
8.4.6.2.3 Market size and forecast, by Anatomy
8.4.6.2.4 Market size and forecast, by Product
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Indication
8.4.6.3.2 Market size and forecast, by Site
8.4.6.3.3 Market size and forecast, by Anatomy
8.4.6.3.4 Market size and forecast, by Product
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Indication
8.4.6.4.2 Market size and forecast, by Site
8.4.6.4.3 Market size and forecast, by Anatomy
8.4.6.4.4 Market size and forecast, by Product
8.4.6.5 Rest Of Asia Pacific
8.4.6.5.1 Market size and forecast, by Indication
8.4.6.5.2 Market size and forecast, by Site
8.4.6.5.3 Market size and forecast, by Anatomy
8.4.6.5.4 Market size and forecast, by Product
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Indication
8.5.3 LAMEA Market size and forecast, by Site
8.5.4 LAMEA Market size and forecast, by Anatomy
8.5.5 LAMEA Market size and forecast, by Product
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Latin America
8.5.6.1.1 Market size and forecast, by Indication
8.5.6.1.2 Market size and forecast, by Site
8.5.6.1.3 Market size and forecast, by Anatomy
8.5.6.1.4 Market size and forecast, by Product
8.5.6.2 Middle East
8.5.6.2.1 Market size and forecast, by Indication
8.5.6.2.2 Market size and forecast, by Site
8.5.6.2.3 Market size and forecast, by Anatomy
8.5.6.2.4 Market size and forecast, by Product
8.5.6.3 Africa
8.5.6.3.1 Market size and forecast, by Indication
8.5.6.3.2 Market size and forecast, by Site
8.5.6.3.3 Market size and forecast, by Anatomy
8.5.6.3.4 Market size and forecast, by Product
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Abbott Laboratories
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Becton, Dickinson and Company
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cardinal Health Inc
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 cook medical
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Endologix Inc
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Lombard Medical Inc
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Medtronic Plc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Koninklijke Philips N.V.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Terumo Medical Corporation
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 W. L. Gore & Associates Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 2. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY REGION , 2020-2030,($MILLION)
TABLE 3. ENDOVASCULAR ANEURYSM REPAIR MARKET ABDOMINAL AORTIC ANEURYSM (AAA) BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR THORATIC AORTIC ANEURYSM (TAA), BY REGION , 2020-2030,($MILLION)
TABLE 5. ENDOVASCULAR ANEURYSM REPAIR MARKET THORATIC AORTIC ANEURYSM (TAA) BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 7. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR INFRARENAL, BY REGION , 2020-2030,($MILLION)
TABLE 8. ENDOVASCULAR ANEURYSM REPAIR MARKET INFRARENAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PARARENAL, BY REGION , 2020-2030,($MILLION)
TABLE 10. ENDOVASCULAR ANEURYSM REPAIR MARKET PARARENAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 12. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR TRADITIONAL, BY REGION , 2020-2030,($MILLION)
TABLE 13. ENDOVASCULAR ANEURYSM REPAIR MARKET TRADITIONAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR COMPLEX, BY REGION , 2020-2030,($MILLION)
TABLE 15. ENDOVASCULAR ANEURYSM REPAIR MARKET COMPLEX BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 17. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PERCUTANEOUS EVAR, BY REGION , 2020-2030,($MILLION)
TABLE 18. ENDOVASCULAR ANEURYSM REPAIR MARKET PERCUTANEOUS EVAR BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR FENESTRATED EVAR, BY REGION , 2020-2030,($MILLION)
TABLE 20. ENDOVASCULAR ANEURYSM REPAIR MARKET FENESTRATED EVAR BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR AORTIC STENTS & TAA GRAFT, BY REGION , 2020-2030,($MILLION)
TABLE 22. ENDOVASCULAR ANEURYSM REPAIR MARKET AORTIC STENTS & TAA GRAFT BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 24. ENDOVASCULAR ANEURYSM REPAIR MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. ENDOVASCULAR ANEURYSM REPAIR MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 29. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 30. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 32. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 33. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 34. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 35. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 36. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 37. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 38. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 39. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 40. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 41. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 42. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 43. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 44. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 45. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 46. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 47. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 48. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 49. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 50. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 51. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 52. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 53. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 54. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 55. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 56. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 57. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 58. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 59. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 60. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 61. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 62. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 63. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 64. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 65. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 66. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 67. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 68. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 69. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 70. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 71. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 72. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 73. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 74. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 75. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 76. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 77. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 78. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 79. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 80. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 81. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 82. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 83. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 84. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 85. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 86. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 87. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 88. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 89. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 90. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 91. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 92. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 93. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 94. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 95. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 96. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 97. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 98. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 99. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 100. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 101. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 102. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 103. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 104. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 105. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 106. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 107. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 108. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 109. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 110.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 111.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 112.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 113.ABBOTT LABORATORIES: NET SALES,
TABLE 114.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 118.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 119.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 120.CARDINAL HEALTH INC: COMPANY SNAPSHOT
TABLE 121.CARDINAL HEALTH INC: OPERATING SEGMENTS
TABLE 122.CARDINAL HEALTH INC: PRODUCT PORTFOLIO
TABLE 123.CARDINAL HEALTH INC: NET SALES,
TABLE 124.CARDINAL HEALTH INC: KEY STRATERGIES
TABLE 125.COOK MEDICAL: COMPANY SNAPSHOT
TABLE 126.COOK MEDICAL: OPERATING SEGMENTS
TABLE 127.COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 128.COOK MEDICAL: NET SALES,
TABLE 129.COOK MEDICAL: KEY STRATERGIES
TABLE 130.ENDOLOGIX INC: COMPANY SNAPSHOT
TABLE 131.ENDOLOGIX INC: OPERATING SEGMENTS
TABLE 132.ENDOLOGIX INC: PRODUCT PORTFOLIO
TABLE 133.ENDOLOGIX INC: NET SALES,
TABLE 134.ENDOLOGIX INC: KEY STRATERGIES
TABLE 135.LOMBARD MEDICAL INC: COMPANY SNAPSHOT
TABLE 136.LOMBARD MEDICAL INC: OPERATING SEGMENTS
TABLE 137.LOMBARD MEDICAL INC: PRODUCT PORTFOLIO
TABLE 138.LOMBARD MEDICAL INC: NET SALES,
TABLE 139.LOMBARD MEDICAL INC: KEY STRATERGIES
TABLE 140.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 141.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 142.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 143.MEDTRONIC PLC: NET SALES,
TABLE 144.MEDTRONIC PLC: KEY STRATERGIES
TABLE 145.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 146.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 147.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 148.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 149.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 150.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 151.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 152.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 153.TERUMO MEDICAL CORPORATION: NET SALES,
TABLE 154.TERUMO MEDICAL CORPORATION: KEY STRATERGIES
TABLE 155.W. L. GORE & ASSOCIATES INC: COMPANY SNAPSHOT
TABLE 156.W. L. GORE & ASSOCIATES INC: OPERATING SEGMENTS
TABLE 157.W. L. GORE & ASSOCIATES INC: PRODUCT PORTFOLIO
TABLE 158.W. L. GORE & ASSOCIATES INC: NET SALES,
TABLE 159.W. L. GORE & ASSOCIATES INC: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.ENDOVASCULAR ANEURYSM REPAIR MARKET SEGMENTATION
FIGURE 2.ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030
FIGURE 3.ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.ENDOVASCULAR ANEURYSM REPAIR MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY INDICATION,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ABDOMINAL AORTIC ANEURYSM (AAA) ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF THORATIC AORTIC ANEURYSM (TAA) ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 14.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY SITE,2020(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF INFRARENAL ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PARARENAL ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 17.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY ANATOMY,2020(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF TRADITIONAL ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF COMPLEX ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 20.ENDOVASCULAR ANEURYSM REPAIR MARKET,BY PRODUCT,2020(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF PERCUTANEOUS EVAR ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF FENESTRATED EVAR ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF AORTIC STENTS & TAA GRAFT ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030(%)
FIGURE 25.ENDOVASCULAR ANEURYSM REPAIR MARKET BY REGION,2020
FIGURE 26.U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 27.CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 28.MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 29.GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 30.ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 31.FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 32.SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 33.REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 34.CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 35.JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 36.INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 37.SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 38.REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 39.LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 40.MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 41.AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET,2020-2030($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46.COMPETITIVE DASHBOARD
FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 49.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
FIGURE 50.CARDINAL HEALTH INC.: NET SALES ,($MILLION)
FIGURE 51.COOK MEDICAL.: NET SALES ,($MILLION)
FIGURE 52.ENDOLOGIX INC.: NET SALES ,($MILLION)
FIGURE 53.LOMBARD MEDICAL INC.: NET SALES ,($MILLION)
FIGURE 54.MEDTRONIC PLC.: NET SALES ,($MILLION)
FIGURE 55.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
FIGURE 56.TERUMO MEDICAL CORPORATION.: NET SALES ,($MILLION)
FIGURE 57.W. L. GORE & ASSOCIATES INC.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global endovascular aneurysm repair market was valued at $2,646.6 million in 2020 and is projected to reach $4,356.2 million by 2030, growing at a CAGR of 4.8% from 2020 to 2030.
Endovascular aneurysm repair (EVAR) is an preferred treatment option for aortic aneurysm, owing to its advantages over open surgery. These advantages include shorter hospital stay, quick recovery time, improved patient outcomes, and no abdominal surgery. Hence, this EVAR procedure is known as standard intervention for abdominal aortic aneurysm (AAA). In this procedure, a stent is placed in aneurysmal area of the aorta to provide permanent alternative channel for blood flow within the patient’s vasculature, thereby preventing aneurysmal sac from blood flow pressure and rupturing.
Although EVAR has significantly reduced operative risks and recovery time as compared to conventional open surgery, it is still possible to make improvements to the EVAR.. This is attributed to the fact that there have been cases of endoleaks post EVAR procedure. However, to meet such challenges, market players have developed next generation advanced technologies. For instance, Endologix Inc. received FDA approval for its percutaneous endograft delivery system and has a game-changing new generation Nellix technology, the first and only endovascular sealing product beneficial in preventing all types of endoleaks.

The increase in vascular diseases among population such as pulmonary embolism, cardiac disorders, and atherosclerosis, rise the demand for grafts for treatment, which, in turn, drives the growth of the EVAR market. . Furthermore, government is taking initiatives to increase awareness related to availability of aneurysm treatment procedures and devices. Inflated cost associated with EVAR treatment procedures and lack of awareness among people are some of the factors expected to hamper the growth of the market

The major players such as Terumo Medical Corporation, Koninklijike Philips N.V., and Medtronic PLC. are adopting the product launch strategy to improve their product portfolio to maintain competition in the market. For instance, in December 2020, Terumo launched the first commercial case of aortic balloon in the U.S. This device assists physicians in the expansion of aorta, using TREO and RELAY stent-grafts in endovascular aortic repair. Such instances are expected to provide lucrative opportunities to the major players for the growth of the market.
The COVID-19 pandemic forced many companies in the global EVAR market to halt business operations for short term to comply with new government regulations, limiting the spread of the disease. This halt in operations directly impacted revenue flow of the global EVAR market. In addition, there was a halt in manufacturing of industrial products, owing to lack of raw materials and manpower in the lockdown period. Furthermore, no new consignments were received by companies that operated in this sector. Hence, halt in industrial activities and lockdowns for several months affected the global EVAR market, experiencing a gradual recovery during the forecast period.

The EVAR market is segmented on the basis of indication, products, site, anatomy, and region. Depending on indication, it is divided into AAA and thoracic aortic aneurysm (TAA). According to site, it is bifurcated into infrarenal and pararenal. As per the anatomy, it is categorized into traditional and complex. By product, it is segregated into percutaneous EVAR, fenestrated EVAR, aortic stents & TAA grafts and others. . By indication, the AAA segment occupied dominant share of 77.9% in 2020, and TAA is expected maintain this trend during the forecast period, owing to high occurrences of AAA disease across the globe.
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to hold the highest market share during the forecast period.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（個々の器官作用薬）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（repair）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（個々の器官作用薬）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（repair）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?